We measured plasma and/or serum antibody responses to the receptor-binding domain (RBD)
of the spike (S) protein of SARS-CoV-2 in 343 North American patients infected with …

INTRODUCTION We used genomic epidemiology to investigate the introduction and spread
of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Boston area …

The SARS-CoV-2 Delta variant rose to dominance in mid-2021, likely propelled by an
estimated 40%–80% increased transmissibility over Alpha. To investigate if this ostensible …

Many studies have examined the impact of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) variants on neutralizing antibody activity after they have become dominant …

We enrolled 7 individuals with recurrent symptoms or antigen test conversion following
nirmatrelvir-ritonavir treatment. High viral loads (median 6.1 log 10 copies/mL) were detected …

RSV Surge and Viral Lineages, 2022 A surge in RSV infections occurred across the United
States in late 2022. In this report, multiple RSV lineages are identified as contributing to the …

Candida auris is an emerging, often multidrug-resistant pathogen with important public health
implications. Infections are associated with high mortality, and prevention of transmission …

Sensitive and specific severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
serologic assays are needed to inform diagnostic, therapeutic, and public health decision-making…

International travel is a contributor to the acquisition and dissemination of AMR organisms
globally. Efforts to reduce the burden of AMR organisms should include a focus on …

Background Culture-based studies have shown that acquisition of extended-spectrum β-lactamase-producing
Enterobacterales is common during international travel; however, little is …